Literature DB >> 32343775

SARS-CoV-2 Serology: Much Hype, Little Data.

Christopher W Farnsworth1, Neil W Anderson1.   

Abstract

Entities:  

Keywords:  COVID-19; serology

Mesh:

Substances:

Year:  2020        PMID: 32343775      PMCID: PMC7197624          DOI: 10.1093/clinchem/hvaa107

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  35 in total

Review 1.  Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.

Authors:  Carmen Charlton; Jamil Kanji; Vanessa Tran; Julianne Kus; Jonathan Gubbay; Carla Osiowy; Jason Robinson; Inna Sekirov; Michael Drebot; Todd Hatchette; Derek Stein; Nadia El-Gabalawy; Amanda Lang; Lei Jiao; Paul Levett; Heidi Wood; Christian Therrien; L Robbin Lindsay; Muhammad Morshed; Jessica Forbes; Antonia Dibernardo
Journal:  Can Commun Dis Rep       Date:  2021-05-07

2.  CAN IgG ANTIBODIES DIRECTED AGAINST DIFFERENT TARGETS SOLVE THE PROBLEM OF FALSE-POSITIVE RESULTS IN SARS-CoV-2 SEROLOGY?

Authors:  Nataša Beader; Ivana Mareković
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

3.  Capillary whole-blood IgG-IgM COVID-19 self-test as a serological screening tool for SARS-CoV-2 infection adapted to the general public.

Authors:  Serge Tonen-Wolyec; Raphael Dupont; Salomon Batina-Agasa; Marie-Pierre Hayette; Laurent Bélec
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

4.  Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies.

Authors:  Gang Xu; Anthony J Emanuel; Satish Nadig; Shikhar Mehrotra; Brittany A Caddell; Scott R Curry; Frederick S Nolte; Nikolina Babic
Journal:  Clin Chem       Date:  2020-09-07       Impact factor: 8.327

5.  SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

Authors:  Marie-Luise Buchholtz; Florian M Arend; Peter Eichhorn; Michael Weigand; Alisa Kleinhempel; Kurt Häusler; Mathias Bruegel; Lesca M Holdt; Daniel Teupser
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

6.  Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK.

Authors:  Naheed Choudhry; Kate Drysdale; Carla Usai; Dean Leighton; Vinay Sonagara; Ruaridh Buchanan; Manreet Nijjar; Sherine Thomas; Mark Hopkins; Teresa Cutino-Moguel; Upkar S Gill; Graham R Foster; Patrick T Kennedy
Journal:  Front Med (Lausanne)       Date:  2021-04-27

7.  Unexpected False-Positive Rates in Pediatric SARS-CoV-2 Serology Using the EUROIMMUN Anti-SARS-CoV-2 ELISA IgG Assay.

Authors:  Daniel Geisler; Megan Culler Freeman; Glenn J Rapsinski; Sarah E Wheeler
Journal:  Am J Clin Pathol       Date:  2021-05-18       Impact factor: 2.493

8.  Cross-Institutional Evaluation of the Abbott ARCHITECT SARS-CoV-2 IgG Immunoassay.

Authors:  Joesph R Wiencek; Lorin M Bachmann; Kelly Dinwiddie; Greg W Miller; Lindsay A L Bazydlo
Journal:  Lab Med       Date:  2021-04-30

9.  Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: A meta-analysis.

Authors:  Zu-Li Zhang; Yu-Lei Hou; De-Tao Li; Feng-Zeng Li
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

10.  Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.

Authors:  Julien Favresse; Christine Eucher; Marc Elsen; Carlos Graux; Paul Goebels; Kim Laffineur; Jean-Baptiste Nicolas; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Br J Haematol       Date:  2020-07-09       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.